Search research articles
Contact Us
Filters
Showing results (11-20 of 209) with videos related to
Page
of 21
Sort By:
European Urology
|
January 23, 2014
Predicting biochemical recurrence following salvage radiotherapy: applying lessons learned from primary radiotherapy
Stephen B Williams, Jim C Hu
BJU International
|
February 27, 2016
Optimum management of non-muscle-invasive micropapillary variant urothelial carcinoma: possibility for missed chance of cure?
Stephen B Williams, Ashish M Kamat
European Urology Oncology
|
May 20, 2019
Reply from Authors re: Peter Albers. Volume Matters: Can We Rely on the Evidence? Eur Urol Oncol 2019;2:274-5
Stephen B Williams, James W F Catto
Cancer
|
August 6, 2021
Fear of cancer recurrence among patients with localized prostate cancer
Cristiane Decat Bergerot, Stephen B Williams, Zachary Klaassen
Pharmacoeconomics
|
April 23, 2023
Cost-Effectiveness and Economic Impact of Bladder Cancer Management: An Updated Review of the Literature
Daniel D Joyce, Vidit Sharma, Stephen B Williams
JAMA Oncology
|
July 17, 2015
Watchful Waiting-Active Surveillance in Low-Risk Prostate Cancer-Reply
Stephen B Williams, Karim Chamie, Jim C Hu
Translational Andrology and Urology
|
January 18, 2021
Vesical imaging reporting and data system (VI-RADS) and impact on identifying depth of invasion with subsequent management in bladder cancer patients: ready for prime time?
Brian S Wong, Cihan Duran, Stephen B Williams
Urology
|
July 9, 2016
Editorial Comment
Cameron Ghaffary, Tamer J Dafashy, Stephen B Williams
JAMA Oncology
|
July 17, 2015
Population-Based Assessment of Determining Treatments for Prostate Cancer
Karim Chamie, Stephen B Williams, Jim C Hu
The Urologic Clinics of North America
|
October 13, 2014
Economics of robotic surgery: does it make sense and for whom?
Stephen B Williams, Kris Prado, Jim C Hu
Page
of 21
Search research articles
Search
Showing results (11-20 of 209) with videos related to
Sort By:
Page
of 21
European Urology
|
January 23, 2014
Predicting biochemical recurrence following salvage radiotherapy: applying lessons learned from primary radiotherapy
Stephen B Williams, Jim C Hu
BJU International
|
February 27, 2016
Optimum management of non-muscle-invasive micropapillary variant urothelial carcinoma: possibility for missed chance of cure?
Stephen B Williams, Ashish M Kamat
European Urology Oncology
|
May 20, 2019
Reply from Authors re: Peter Albers. Volume Matters: Can We Rely on the Evidence? Eur Urol Oncol 2019;2:274-5
Stephen B Williams, James W F Catto
Cancer
|
August 6, 2021
Fear of cancer recurrence among patients with localized prostate cancer
Cristiane Decat Bergerot, Stephen B Williams, Zachary Klaassen
Pharmacoeconomics
|
April 23, 2023
Cost-Effectiveness and Economic Impact of Bladder Cancer Management: An Updated Review of the Literature
Daniel D Joyce, Vidit Sharma, Stephen B Williams
JAMA Oncology
|
July 17, 2015
Watchful Waiting-Active Surveillance in Low-Risk Prostate Cancer-Reply
Stephen B Williams, Karim Chamie, Jim C Hu
Translational Andrology and Urology
|
January 18, 2021
Vesical imaging reporting and data system (VI-RADS) and impact on identifying depth of invasion with subsequent management in bladder cancer patients: ready for prime time?
Brian S Wong, Cihan Duran, Stephen B Williams
Urology
|
July 9, 2016
Editorial Comment
Cameron Ghaffary, Tamer J Dafashy, Stephen B Williams
JAMA Oncology
|
July 17, 2015
Population-Based Assessment of Determining Treatments for Prostate Cancer
Karim Chamie, Stephen B Williams, Jim C Hu
The Urologic Clinics of North America
|
October 13, 2014
Economics of robotic surgery: does it make sense and for whom?
Stephen B Williams, Kris Prado, Jim C Hu
Page
of 21